123 related articles for article (PubMed ID: 31164539)
1. [A Case of a Patient with Locally Recurrent Rectal Cancer Who Underwent Surgical Resection after Chemotherapy with FOLFOXIRI plus Bevacizumab].
Shigoka M; Enomoto M; Wada T; Mazaki J; Kuwabara H; Ishizaki T; Ishibashi Y; Nagakawa Y; Katsumata K; Tsuchida A
Gan To Kagaku Ryoho; 2019 Apr; 46(4):796-798. PubMed ID: 31164539
[TBL] [Abstract][Full Text] [Related]
2. [Two Cases of Metastatic Rectal Cancer Patients Who Received Chemotherapy with FOLFOXIRI plus Bevacizumab].
Nishii T; Uchima Y; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Aomatsu N; Iwauchi T; Morimoto J; Nakazawa K; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1705-1707. PubMed ID: 28133105
[TBL] [Abstract][Full Text] [Related]
3. [Locally Advanced Rectal Cancer Curatively Resected after Modified FOLFOXIRI plus Bevacizumab Chemotherapy-A Case Report].
Yamaguchi S; Kobayashi K; Inoue Y; Torashima Y; Ito S; Kanetaka K; Takatsuki M; Eguchi S
Gan To Kagaku Ryoho; 2020 Mar; 47(3):453-455. PubMed ID: 32381914
[TBL] [Abstract][Full Text] [Related]
4. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial.
Masi G; Vivaldi C; Fornaro L; Lonardi S; Buccianti P; Sainato A; Marcucci L; Martignetti A; Luca Urso ED; Castagna M; Fontanini G; Bergamo F; Musettini G; Urbani L; Sensi E; Balestri R; Montrone S; Pasqualetti F; Cremolini C; Di Paolo A; Zagonel V; Falcone A
Eur J Cancer; 2019 Mar; 110():32-41. PubMed ID: 30739838
[TBL] [Abstract][Full Text] [Related]
5. Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation.
Bensignor T; Brouquet A; Dariane C; Thirot-Bidault A; Lazure T; Julié C; Nordlinger B; Penna C; Benoist S
Colorectal Dis; 2015 Jun; 17(6):491-8. PubMed ID: 25524450
[TBL] [Abstract][Full Text] [Related]
6. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial.
Masi G; Loupakis F; Salvatore L; Fornaro L; Cremolini C; Cupini S; Ciarlo A; Del Monte F; Cortesi E; Amoroso D; Granetto C; Fontanini G; Sensi E; Lupi C; Andreuccetti M; Falcone A
Lancet Oncol; 2010 Sep; 11(9):845-52. PubMed ID: 20702138
[TBL] [Abstract][Full Text] [Related]
8. [A Long-Survival Case of Lower Rectal Cancer with Unresectable Liver Metastases Treated with FOLFOXIRI plus Bevacizumab(BEV)].
Kagawa Y; Inoue A; Nishizawa Y; Kawai K; Ohta T; Hata T; Naito A; Komatsu H; Miyazaki Y; Tomokuni A; Motoori M; Fujitani K; Kato T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1819-1821. PubMed ID: 35046341
[TBL] [Abstract][Full Text] [Related]
9. Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis.
Shui L; Wu YS; Lin H; Shui P; Sun Q; Chen X
Cell Physiol Biochem; 2018; 48(5):1870-1881. PubMed ID: 30092572
[TBL] [Abstract][Full Text] [Related]
10. [Two Cases of Advanced Colorectal Cancer Achieving Complete Response by FOLFOXIRI plus Bevacizumab-A Case Report].
Nemoto T; Endo S; Isohata N; Takayanagi D; Nemoto D; Aizawa M; Utano K; Togashi K; Oshibe I; Soeta N; Saito T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2410-2412. PubMed ID: 32156948
[TBL] [Abstract][Full Text] [Related]
11. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
[TBL] [Abstract][Full Text] [Related]
12. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Complete Pathological Response in a Patient with Advanced Ascending Colon Cancer That Invaded the Liver and Duodenum after FOLFOXIRI plus Bevacizumab Chemotherapy].
Naito A; Kagawa Y; Kawai K; Takeno A; Takeda Y; Ohtsuka M; Suzuki Y; Imasato M; Fujie Y; Nakaba H; Akamatsu H; Murata K
Gan To Kagaku Ryoho; 2020 Feb; 47(2):298-300. PubMed ID: 32381968
[TBL] [Abstract][Full Text] [Related]
14. [A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab].
Iseki Y; Maeda K; Shibutani M; Nagahara H; Ikeya T; Tamura T; Ohira G; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2205-7. PubMed ID: 26805312
[TBL] [Abstract][Full Text] [Related]
15. [Conversion Therapy of Initially Unresectable Rectal Cancer with Perforation via FOLFOX4 Chemotherapy].
Yamada C; Ishikawa F; Nitta H; Fujita Y; Omoto H; Kamata S; Ito H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2328-9. PubMed ID: 26805353
[TBL] [Abstract][Full Text] [Related]
16. [A Case of a Patient with Rectum Cancer with Multiple Metastases, Who Was Able to Undergo Conversion Therapy Using Alternating mFOLFOX6 and FOLFIRI Regimens in Combination with Alternating Cetuximab and Bevacizumab].
O'hara H; Yamamoto H
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1669-1672. PubMed ID: 30449861
[TBL] [Abstract][Full Text] [Related]
17. [Surgical resection after chemotherapy for advanced rectal cancer - report of a case].
Suda K; Kameyama H; Shimada Y; Sakata J; Kobayashi T; Nogami H; Minagawa M; Kosugi S; Koyama Y; Wakai T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1572-4. PubMed ID: 25731256
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Bilateral Lymph Node Metastases of Rectal Cancer Treated with Chemotherapy and Surgery].
Tate T; Fukui Y; Tomizawa K; Hanaoka Y; Toda S; Matoba S; Kuroyanagi H
Gan To Kagaku Ryoho; 2017 Oct; 44(10):871-873. PubMed ID: 29066682
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Preoperative Chemotherapy with Modified OPTIMOX-1 Plus Bevacizumab in Patients with Advanced Rectal Cancer with Factors Contraindicative of Curative Surgery.
Kosugi C; Koda K; Tanaka K; Suzuki M; Yamazaki M; Shuto K; Matsuo K; Hirano A; Arimitsu H; Shiragami R; Yasuda H
Hepatogastroenterology; 2015 Jun; 62(140):868-72. PubMed ID: 26902018
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced rectal cancer treated with leucovorin, fluorouracil, and oxaliplatin plus panitumumab preoperative chemotherapy].
Takahashi H; Ishikawa T; Iwata N; Baba H; Masuda T; Okazaki S; Matsuyama T; Ishiguro M; Kobayashi H; Iida S; Uetake H; Sugihara K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1953-5. PubMed ID: 24393977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
